Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-04-08 Purchase | 2024-04-10 5:16 pm | BioRestorative Therapies Inc. | BRTX | Silva Francisco VP of Research and Development | 8,308 | $1.2313 | $10,229 | 1,005,007 (Indirect Direct) | View |
| 2023-08-31 Purchase | 2023-08-31 1:54 pm | BioRestorative Therapies Inc. | BRTX | Silva Francisco VP of Research and Development 10% Owner | 4,954 | $2.22 | $10,998 | 619,160 (Indirect Direct) | View |
| 2023-03-31 Purchase | 2023-04-04 07:00 am | BioRestorative Therapies Inc. | BRTX | Silva Francisco VP of Research and Development 10% Owner | 747 | $3.56 | $2,659 | 614,206 (Indirect Direct) | View |
| 2022-11-21 Purchase | 2022-11-21 5:14 pm | BioRestorative Therapies Inc. | BRTX | Silva Francisco VP of Research and Development | 943 | $2.6162 | $2,467 | 513,801 (Indirect Direct) | View |
| 2022-10-12 Purchase | 2022-10-12 2:01 pm | BioRestorative Therapies Inc. | BRTX | Silva Francisco VP of Research and Development | 725 | $3.3884 | $2,457 | 512,858 (Indirect Direct) | View |
| 2022-10-11 Purchase | 2022-10-12 08:54 am | BioRestorative Therapies Inc. | BRTX | Silva Francisco VP of Research and Development | 806 | $3.6886 | $2,973 | 512,133 (Indirect Direct) | View |
| 2022-08-26 Purchase | 2022-09-09 6:17 pm | BioRestorative Therapies Inc. | BRTX | Silva Francisco VP of Research and Development | 5,723 | $3.2809 | $18,777 | 511,327 (Indirect Direct) | View |
| 2022-08-26 Sale | 2022-09-09 6:17 pm | BioRestorative Therapies Inc. | BRTX | Silva Francisco VP of Research and Development | 3,958 | $3.388 | $13,410 | 511,327 (Indirect Direct) | View |
| 2021-11-19 Purchase | 2021-11-22 12:17 pm | BioRestorative Therapies Inc. | BRTX | Silva Francisco VP of Research and Development | 4,000 | $6.6565 | $26,626 | 496,299 (Indirect Direct) | View |
| 2021-11-16 Purchase | 2021-11-16 5:23 pm | BioRestorative Therapies Inc. | BRTX | Silva Francisco VP of Research and Development | 7,826 | $6.7252 | $52,632 | 492,299 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-18 Tax Withholding | 2024-03-20 4:38 pm | N/A N/A | BioRestorative Therapies Inc. | BRTX | Silva Francisco VP of Research and Development | 17,193 | $1.39 | 996,699 (Direct) | View |
| 2024-02-13 Option Award | 2024-02-15 4:13 pm | N/A 2034-02-13 | BioRestorative Therapies Inc. | BRTX | Silva Francisco VP of Research and Development 10% Owner | 394,737 | $0 | 1,013,896 (Direct) | View |
| 2023-03-20 Tax Withholding | 2023-03-22 4:49 pm | N/A N/A | BioRestorative Therapies Inc. | BRTX | Silva Francisco VP of Research and Development 10% Owner | 6,729 | $2.92 | 613,459 (Direct) | View |
| 2023-02-18 Tax Withholding | 2023-02-28 07:26 am | N/A N/A | BioRestorative Therapies Inc. | BRTX | Silva Francisco VP of Research and Development 10% Owner | 374 | $2.99 | 620,188 (Direct) | View |
| 2023-02-17 Option Award | 2023-02-17 5:29 pm | N/A 2033-02-17 | BioRestorative Therapies Inc. | BRTX | Silva Francisco VP of Research and Development 10% Owner | 106,762 | $0 | 620,562 (Direct) | View |
| 2022-11-03 Option Award | 2022-11-04 4:27 pm | N/A 2031-03-18 | BioRestorative Therapies Inc. | BRTX | Silva Francisco VP of Research and Development | 335,538 | $0 | 512,858 (Direct) | View |
| 2022-11-03 Disposition | 2022-11-04 4:27 pm | N/A 2031-03-18 | BioRestorative Therapies Inc. | BRTX | Silva Francisco VP of Research and Development | 335,538 | $0 | 512,858 (Direct) | View |
| 2022-06-14 Option Award | 2022-06-15 2:55 pm | N/A N/A | BioRestorative Therapies Inc. | BRTX | Silva Francisco VP of Research and Development | 263 | $3.7774 | 509,563 (Direct) | View |
| 2022-06-07 Option Award | 2022-06-08 09:37 am | N/A N/A | BioRestorative Therapies Inc. | BRTX | Silva Francisco VP of Research and Development | 565 | $4.6493 | 509,300 (Direct) | View |
| 2022-03-18 Option Award | 2022-03-22 5:11 pm | N/A N/A | BioRestorative Therapies Inc. | BRTX | Silva Francisco VP of Research and Development | 12,438 | $0 | 508,736 (Direct) | View |
| 2021-11-04 Option Award | 2021-11-08 5:35 pm | N/A 2031-03-18 | BioRestorative Therapies Inc. | BRTX | Silva Francisco VP of Research and Development | 335,538 | $0 | 484,474 (Direct) | View |
| 2021-11-04 Disposition | 2021-11-08 5:35 pm | N/A 2031-03-18 | BioRestorative Therapies Inc. | BRTX | Silva Francisco VP of Research and Development | 293,479 | $0 | 484,474 (Direct) | View |
| 2021-03-18 Option Award | 2021-03-19 5:05 pm | N/A 2031-03-18 | BioRestorative Therapies Inc. | BRTX | Silva Francisco VP of Research and Development 10% Owner | 1,760,876,961 | $0 | 1,769,661,356 (Direct) | View |
| 2020-11-23 Other | 2020-11-24 4:02 pm | N/A N/A | BioRestorative Therapies Inc. | BRTX | Silva Francisco VP of Research and Development | 8,375,671 | $0 | 17,160,066 (Direct) | View |